APO RESEARCH · REPORT
Breast Biopsy Devices
Breast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous. Breast Biopsy Devices means include biopsy needles, biopsy tables, localization wires, guidance systems and others.
Product & engineering
Understand the product.
Breast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous. Breast Biopsy Devices means include biopsy needles, biopsy tables, localization wires, guidance systems and others.
Selected research
Market Outlook & Growth Opportunities
Global Breast Biopsy Devices Market Outlook and Growth Opportunities 2026
Market perspective
Breast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous. Breast Biopsy Devices means include biopsy needles, biopsy tables, localization wires, guidance systems and others.
Global Breast Biopsy Devices key players include Mammotome, Hologic, C.R Bard, BD, etc. North America is the largest market, with a share over 50%, followed by Europe, which has a share over 25 percent. In terms of product, Guidance Systems is the largest segment, with a share over 30%. In terms of application, Hospital is the largest market, with a share over 70%.
This report provides an overview of the global Breast Biopsy Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Breast Biopsy Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Breast Biopsy Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Breast Biopsy Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Breast Biopsy Devices Segment by Company
Mammotome
Hologic
C.R Bard
BD
Stryker
Galini SRL
Medtronic
Izi Medical Products
Trivitron
Scion Medical
Breast Biopsy Devices Segment by Type
Biopsy Needles
Biopsy Tables
Guidance Systems
Localization Wires
Others
Breast Biopsy Devices Segment by Application
Hospital
Clinic
Breast Biopsy Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Breast Biopsy Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Breast Biopsy Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Breast Biopsy Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Breast Biopsy Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Biopsy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast Biopsy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Biopsy Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Breast Biopsy Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Breast Biopsy Devices industry.
Chapter 3: Detailed analysis of Breast Biopsy Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Breast Biopsy Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Breast Biopsy Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Biopsy Needles
- Biopsy Tables
- Guidance Systems
- Localization Wires
- Others
Applications
- Hospital
- Clinic
Companies covered
- Mammotome
- Hologic
- C.R Bard
- BD
- Stryker
- Galini SRL
- Medtronic
- Izi Medical Products
- Trivitron
- Scion Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Breast Biopsy Devices Sales Value (2021-2032)
- 1.2.2 Global Breast Biopsy Devices Sales Volume (2021-2032)
- 1.2.3 Global Breast Biopsy Devices Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Breast Biopsy Devices Market Dynamics
- 2.1 Breast Biopsy Devices Industry Trends
- 2.2 Breast Biopsy Devices Industry Drivers
- 2.3 Breast Biopsy Devices Industry Opportunities and Challenges
- 2.4 Breast Biopsy Devices Industry Restraints
3 Breast Biopsy Devices Market by Company
- 3.1 Global Breast Biopsy Devices Company Revenue Ranking in 2025
- 3.2 Global Breast Biopsy Devices Revenue by Company (2021-2026)
- 3.3 Global Breast Biopsy Devices Sales Volume by Company (2021-2026)
- 3.4 Global Breast Biopsy Devices Average Price by Company (2021-2026)
- 3.5 Global Breast Biopsy Devices Company Ranking (2024-2026)
- 3.6 Global Breast Biopsy Devices Company Manufacturing Base and Headquarters
- 3.7 Global Breast Biopsy Devices Company Product Type and Application
- 3.8 Global Breast Biopsy Devices Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Breast Biopsy Devices Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Breast Biopsy Devices Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Breast Biopsy Devices Market by Type
- 4.1 Breast Biopsy Devices Type Introduction
- 4.1.1 Biopsy Needles
- 4.1.2 Biopsy Tables
- 4.1.3 Guidance Systems
- 4.1.4 Localization Wires
- 4.1.5 Others
- 4.2 Global Breast Biopsy Devices Sales Volume by Type
- 4.2.1 Global Breast Biopsy Devices Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Breast Biopsy Devices Sales Volume by Type (2021-2032)
- 4.2.3 Global Breast Biopsy Devices Sales Volume Share by Type (2021-2032)
- 4.3 Global Breast Biopsy Devices Sales Value by Type
- 4.3.1 Global Breast Biopsy Devices Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Breast Biopsy Devices Sales Value by Type (2021-2032)
- 4.3.3 Global Breast Biopsy Devices Sales Value Share by Type (2021-2032)
5 Breast Biopsy Devices Market by Application
- 5.1 Breast Biopsy Devices Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Breast Biopsy Devices Sales Volume by Application
- 5.2.1 Global Breast Biopsy Devices Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Breast Biopsy Devices Sales Volume by Application (2021-2032)
- 5.2.3 Global Breast Biopsy Devices Sales Volume Share by Application (2021-2032)
- 5.3 Global Breast Biopsy Devices Sales Value by Application
- 5.3.1 Global Breast Biopsy Devices Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Breast Biopsy Devices Sales Value by Application (2021-2032)
- 5.3.3 Global Breast Biopsy Devices Sales Value Share by Application (2021-2032)
6 Breast Biopsy Devices Regional Sales and Value Analysis
- 6.1 Global Breast Biopsy Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Breast Biopsy Devices Sales by Region (2021-2032)
- 6.2.1 Global Breast Biopsy Devices Sales by Region: 2021-2026
- 6.2.2 Global Breast Biopsy Devices Sales by Region (2027-2032)
- 6.3 Global Breast Biopsy Devices Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Breast Biopsy Devices Sales Value by Region (2021-2032)
- 6.4.1 Global Breast Biopsy Devices Sales Value by Region: 2021-2026
- 6.4.2 Global Breast Biopsy Devices Sales Value by Region (2027-2032)
- 6.5 Global Breast Biopsy Devices Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Breast Biopsy Devices Sales Value (2021-2032)
- 6.6.2 North America Breast Biopsy Devices Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Breast Biopsy Devices Sales Value (2021-2032)
- 6.7.2 Europe Breast Biopsy Devices Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Breast Biopsy Devices Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Breast Biopsy Devices Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Breast Biopsy Devices Sales Value (2021-2032)
- 6.9.2 South America Breast Biopsy Devices Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Breast Biopsy Devices Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Breast Biopsy Devices Sales Value Share by Country, 2025 VS 2032
7 Breast Biopsy Devices Country-level Sales and Value Analysis
- 7.1 Global Breast Biopsy Devices Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Breast Biopsy Devices Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Breast Biopsy Devices Sales by Country (2021-2032)
- 7.3.1 Global Breast Biopsy Devices Sales by Country (2021-2026)
- 7.3.2 Global Breast Biopsy Devices Sales by Country (2027-2032)
- 7.4 Global Breast Biopsy Devices Sales Value by Country (2021-2032)
- 7.4.1 Global Breast Biopsy Devices Sales Value by Country (2021-2026)
- 7.4.2 Global Breast Biopsy Devices Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.9.2 France Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.16.2 China Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.19.2 India Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Breast Biopsy Devices Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Breast Biopsy Devices Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Breast Biopsy Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Mammotome
- 8.1.1 Mammotome Company Information
- 8.1.2 Mammotome Business Overview
- 8.1.3 Mammotome Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Mammotome Breast Biopsy Devices Product Portfolio
- 8.1.5 Mammotome Recent Developments
- 8.2 Hologic
- 8.2.1 Hologic Company Information
- 8.2.2 Hologic Business Overview
- 8.2.3 Hologic Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Hologic Breast Biopsy Devices Product Portfolio
- 8.2.5 Hologic Recent Developments
- 8.3 C.R Bard
- 8.3.1 C.R Bard Company Information
- 8.3.2 C.R Bard Business Overview
- 8.3.3 C.R Bard Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.3.4 C.R Bard Breast Biopsy Devices Product Portfolio
- 8.3.5 C.R Bard Recent Developments
- 8.4 BD
- 8.4.1 BD Company Information
- 8.4.2 BD Business Overview
- 8.4.3 BD Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BD Breast Biopsy Devices Product Portfolio
- 8.4.5 BD Recent Developments
- 8.5 Stryker
- 8.5.1 Stryker Company Information
- 8.5.2 Stryker Business Overview
- 8.5.3 Stryker Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Stryker Breast Biopsy Devices Product Portfolio
- 8.5.5 Stryker Recent Developments
- 8.6 Galini SRL
- 8.6.1 Galini SRL Company Information
- 8.6.2 Galini SRL Business Overview
- 8.6.3 Galini SRL Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Galini SRL Breast Biopsy Devices Product Portfolio
- 8.6.5 Galini SRL Recent Developments
- 8.7 Medtronic
- 8.7.1 Medtronic Company Information
- 8.7.2 Medtronic Business Overview
- 8.7.3 Medtronic Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Medtronic Breast Biopsy Devices Product Portfolio
- 8.7.5 Medtronic Recent Developments
- 8.8 Izi Medical Products
- 8.8.1 Izi Medical Products Company Information
- 8.8.2 Izi Medical Products Business Overview
- 8.8.3 Izi Medical Products Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Izi Medical Products Breast Biopsy Devices Product Portfolio
- 8.8.5 Izi Medical Products Recent Developments
- 8.9 Trivitron
- 8.9.1 Trivitron Company Information
- 8.9.2 Trivitron Business Overview
- 8.9.3 Trivitron Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Trivitron Breast Biopsy Devices Product Portfolio
- 8.9.5 Trivitron Recent Developments
- 8.10 Scion Medical
- 8.10.1 Scion Medical Company Information
- 8.10.2 Scion Medical Business Overview
- 8.10.3 Scion Medical Breast Biopsy Devices Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Scion Medical Breast Biopsy Devices Product Portfolio
- 8.10.5 Scion Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Breast Biopsy Devices Value Chain Analysis
- 9.1.1 Breast Biopsy Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Breast Biopsy Devices Sales Mode & Process
- 9.2 Breast Biopsy Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Breast Biopsy Devices Distributors
- 9.2.3 Breast Biopsy Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst